Effects of CD133 on the biological features and in vivo oncogenicity of glioma cells

R. Gao, T T. Sun

Article ID: 5379
Vol 33, Issue 2, 2019
DOI: https://doi.org/10.54517/jbrha5379
Received: 28 November 2018; Accepted: 28 November 2018; Available online: 9 May 2019; Issue release: 9 May 2019

Abstract

This study aimed to investigate the effect of CD133 on the proliferation and migration of glioma cells and expressions of genes related to cancer stem cells/tumor stem cells (CSC/TSC) as well as their in-vivo oncogenicity. CD133-overexpressing U251-CD133 and U251-mock glioma cells were constructed. The effect of CD133 on in-vitro proliferation and the neurosphere-forming ability of glioma cells was determined by cell count and neurosphere formation assay. Real-Time PCR was performed to detect the expressions of CSC/TSC-related genes in the CD133-transfected cells. Nude mouse subcutaneous tumor formation assay was used to determine the effect of CD133 on the in-vivo oncogenicity of glioma cells. In serum-containing medium, human CD133 had no impact on the proliferation of U251 glioma cells, but the neural stem cells placed in serum-free medium promoted neurosphere formation. In the presence of CD133, the expressions of CSC/TSC-related genes were upregulated to varying degrees in glioma cells; CD133 greatly enhanced the in-vivo oncogenicity. In conclusion, CD133 promoted the upregulation of CSC/TSC-related genes in glioma cells, while enhancing the neurosphere-forming ability and in-vivo oncogenicity.


Keywords

glioma;CD133;oncogenicity;biological features


References

Supporting Agencies



Copyright (c) 2019 R. Gao, T T. Sun




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).